drugset / Trial / NCT00020618

Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain

NCT00020618

Phase 2 Completed Dana-Farber Cancer Institute
Supportive care

Summary

RATIONALE: Morphine that is inhaled may be more rapidly absorbed than morphine that is given by mouth. It is not yet known if inhaled morphine is more effective than morphine given by mouth in relieving breakthrough pain. PURPOSE: Randomized phase II trial to compare the effectiveness of inhaled morphine with that of morphine given by mouth in treating cancer patients who have breakthrough pain.

Timeline

Start
2001-03
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified Inhaled